M assive cerebral infarct is one of the most catastrophic forms of ischemic stroke with no proven treatment. Malignant middle cerebral artery (MCA) infarction is a form of massive cerebral infarction that is used to describe complete MCA territory infarction resulting in significant spaceoccupying effect. The resulting depression of consciousness terminates in coma and brain death within 2 to 5 days in almost 80% of patients treated with conservative medical therapy alone. The survivors of this form of stroke are severely disabled with poor quality of life. The incidence is estimated at 2 to 10% of all ischemic stroke. 1 Massive cerebral infarction may be managed both medically and surgically, with little available evidence from randomized controlled studies to guide the choice. Numerous developments have occurred in the medical and surgical management of patients with massive cerebral infarction in the recent past. This article presents a narrative review of the literature concerning the clinical course and medical and neurosurgical management of massive cerebral infarction, highlighting specific areas in which developments are occurring rapidly.
METHODS
The literature was searched from 1970 using MEDLINE and EMBASE with keywords massive cerebral infarcts, hemicraniectomy, malignant MCA infarct, and hypothermia. Articles unavailable for translation were not retrieved. Theoretically, massive cerebral infarcts are large hemispheric infarcts associated with edema and tissue displacements. Only the salient features of management are reviewed here.
CLINICAL COURSE AND PREDICTORS OF CLINICAL DETERIORATION
The clinical course of massive cerebral infarction is determined by the location of vascular occlusion, intrinsic tissue susceptibility, and duration of ischemia. Complete MCA territory infarction is invariably caused by occlusion of the distal internal carotid artery and the proximal MCA trunk (commonly referred to as a T-occlusion or L-occlusion). 1 The etiology of malignant MCA infarction is almost always embolic, either from a proximal cardiac source or carotid disease (dissection, atheroembolic). Anatomic factors such as an incomplete circle of Willis and impaired collateral circulation play a critical role in determining the extent of infarction. The hemodynamic effects of collateral circulation are important in maintaining perfusion to penumbral regions. The extent of infarction is also determined by brain tissue susceptibility to ischemia. For example, susceptibility is augmented by diabetes mellitus. Diabetes mellitus enhances apoptosis induced by cerebral ischemia in rodent models. 2 Reperfusion injury may be another important component cause of massive MCA infarction. Reperfusion of irreversibly damaged brain may enhance edema formation and result in rapid development of swelling (within 24 hours), with hemorrhagic transformation leading to mass effect. These factors commonly result in a fatal outcome. There is a mortality rate of 80% with standard medical treatment alone. 3 Clinically, carotid T-occlusion produces ischemia of the frontoparietal regions, leading to hemianopia and flaccid hemiplegia. Often, these patients have head turning and gaze deviation to the affected hemisphere secondary to involvement of frontal eye fields. Global aphasia due to involvement of the dominant hemisphere or hemispatial neglect from nondominant hemisphere involvement can all be highly disabling. 1, 4, 5 Early identification of patients susceptible for malignant MCA infarction is crucial for appropriate selection of medical and surgical interventions.
The clinical symptoms of worsening neurologic status following a large hemispheric infarct are mainly due to focal ischemic brain edema and focal displacement of brain rather than a global increase in intracranial pressure (ICP). Regional differences in ICP and cerebral perfusion pressure (CPP) play a major role in the exacerbation of cerebral ischemia. A focal increase in ICP in areas of impaired autoregulation around the infarction can cause paradoxic reduction in cerebral perfusion pressure, resulting in ischemia. Focal ICP can lead to focal ischemia when ICP is greater than 20 mmHg, and global ischemia occurs when ICP is greater than 50 mmHg. Patients at risk for ischemic brain edema are those with large hemispheric strokes involving more than 50% of the MCA territory (Fig. 1) . The clinical predictors of early deterioration have been largely derived from numerous case reports. Headache, nausea, vomiting, early somnolence. and respiratory disturbances occur in approximately 50% of patients with malignant MCA infarction as early as 3 hours after stroke onset and may herald mass effect from significant brain edema and early deterioration. These symptoms ideally warrant neurologic intensive care unit (ICU) admission and monitoring. Mass effect with edema usually occurs 1 to 5 days following the ictus, leading to herniation of brain tissue through dural spaces. This can produce subfalcine, transtentorial, uncal, and tonsillar herniation, often resulting in rapid death. 1, [6] [7] [8] Neuroimaging is an invaluable tool for identifying patients at risk for developing ischemic brain edema. Neurologic deterioration correlates with horizontal displacement of the anterior septum and pineal gland on computed tomographic (CT) scan rather than with ICP elevation. The presence of low-density infarction and edema on CT scan that occupies more than 50% of MCA territory is a reliable predictor of subsequent edema formation following a large hemispheric infarct. von Kummer et al 9 have shown that early (Ͻ6 hours) CT scan changes of greater than 50% MCA hypodensity or local brain swelling (effacement of sulci, compression of lateral ventricle) are associated with fatal outcomes in 85% of patients (94% specificity and 61% sensitivity). In addition, hemorrhagic transformation of large hemispheric infarcts may worsen the brain edema and tissue shifts. Barber et al 10 proposed the use of early radiologic signs on follow-up CT scans performed within 48 hours of stroke onset in predicting mortality at 30 days. The CT parameters anteroseptal shift (Ͼ5 mm), pineal shift (Ͼ2 mm), hydrocephalus, temporal lobe infarction, and the presence of other vascular territory infarction were predictive of fatal outcomes. 10 Case reports have also shown that a pineal shift of 2.5 to 4 mm from midline is associated with drowsiness; 6 to 9 mm, with stupor; and greater than 9 mm, with coma. [11] [12] [13] In the European Cooperative Acute Stroke Study, fatal brain edema occurred in patients with baseline (Ͻ6 hours) CT scans showing greater than 33% of MCA involvement. 14 Krieger et al 7 have shown that patients with a baseline National Institutes of Health Stroke Scale (NIHSS) score greater than or equal to 20 points with left hemispheric infarctions, or greater than or equal to 15 points with right hemispheric infarctions within 6 hours of symptom onset accompanied by nausea/vomiting, or more than 50% MCA territory hypodensity on CT scan are at high risk for developing fatal brain edema.
TREATMENT CONSIDERATIONS
Management options for massive cerebral infarction can be classified into medical and surgical. Currently, there are no strict guidelines available from randomized controlled trials. Patients susceptible to the development of massive cerebral infarction should be admitted to a neuro-ICU setting with facilities available for early recognition of brain edema and intervention with an integrated approach between the neurointensivist and the neurosurgeon.
MEDICAL MANAGEMENT
Medical management should focus on prevention of brain edema and tissue displacements. Detailed hemodynamic, neuroimaging, and ICP monitoring are the main tools that should guide management in the neuro-ICU. Current medical therapies have a very limited role in the management of massive cerebral infarction and largely fail to prevent the formation of brain edema and tissue displacement. It should be remembered that early neurologic deterioration is not due to an increase in global ICP and, as a result, therapies that focus on lowering global ICP are not effective. Ideal therapy should be aimed at preventing brain edema, tissue shifts, and secondary increases in ICP.
General Measures
Initial management is aimed at reducing systemic complications. Patients with reduced level of consciousness may be unable to protect their airway, and endotracheal intubation is indicated. There is no evidence to support prophylactic intubation in these patients. 15, 16 Elevation of the head to a 30°a ngle has been shown to reduce ICP, but this may be negated by the reduction in cerebral perfusion. 17 Blood pressure management is a controversial issue in the setting of acute ischemic stroke. There is no evidence to suggest that acute blood pressure lowering in large hemispheric infarcts reduces edema and tissue displacements. Theoretically, lowering blood pressure may reduce disruption of the blood-brain barrier, vasogenic edema, hemorrhagic transformation, and further progression. Conversely, perfusion to the ischemic penumbra (a region where autoregulation of blood flow is no longer active) may be reduced, further exacerbating infarction. A reasonable approach to blood pressure management would be to keep systolic blood pressure less than 220 mmHg 
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and diastolic blood pressure less than 120 mmHg. 18 Hyperglycemia should be managed aggressively with insulin because it has been shown to aggravate brain edema and worsen outcomes. However, this approach is an empiric one because evidence from randomized trials is lacking. Blood glucose levels should be kept below 5 mmol/L by giving intravenous insulin. 19, 20 Fever is associated with poor outcomes in ischemic stroke patients at baseline and should be treated promptly by investigating its underlying cause. 21 Fluid status should be maintained normovolemic with 0.9% sodium chloride and should be monitored using hematocrit, osmolality, and serum sodium. Steroids have no proven role in the management of cerebral edema following ischemic stroke. 22 The general measures are outlined in Table 1 .
Osmotherapy
Hyperosmolar therapy reduces ICP mainly by dehydrating and shrinking the undamaged brain tissue by allowing water to diffuse out in the direction of the osmolar gradient. The duration and degree of ICP reduction depends on the volume of the remaining normal brain tissue, the amount of undamaged blood-brain barrier, initial ICP, and the dose of the agent used. 23, 24 The efficacy of hyperosmolar agents in the treatment of large hemispheric infarcts is not convincing and there have been conflicting reports that suggest these agents may even worsen the ICP and exacerbate the infarction. Hyperosmolar agents are more effective in counteracting global increases in ICP compared with focal. In areas where the blood-brain barrier is disrupted, hyperosmolar agents have been shown to worsen tissue shifts and aggravate brain edema. 25 Rebound edema may occur following discontinuation of these agents. 26, 27 The most common hyperosmolar agents used are mannitol, glycerol, hypertonic saline, albumin, THAM buffer, indomethacin, hetastarch, high-dose barbiturates, and hyperventilation. The optimal timing of therapy with these agents in relation to evolving brain edema is largely unknown. Moreover, differences may exist among these agents. Table 2 outlines the use of hyperosmolar agents and techniques employed in ICP reduction in large hemispheric infarcts.
Hypothermia
Inducing moderate hypothermia (31-33°C) is an emerging therapy that may effectively decrease brain edema and swelling following large hemispheric infarcts. A number of animal and clinical studies have shown that delayed hypothermia has a neuroprotective role in both animal models and clinical research following ischemic stroke by increasing the resistance to ischemia, prolonging the survival of the penumbra, reducing ICP, and minimizing blood-brain barrier disruption. 28 -34 Current evidence suggests that hypothermia reduces cerebral blood flow and metabolism, thereby reducing cerebral edema following head trauma. [35] [36] [37] Multicenter prospective studies have suggested that hypothermia is feasible and safe to use in large hemispheric infarcts. 31, 32 One such study has shown that moderate hypothermia can help control critically elevated ICP values in large hemispheric MCA stroke and may improve clinical outcome in these patients. In this study, hypothermia was induced within 14 hours from stroke onset and was maintained over 72 hours to minimize brain edema. External cooling was induced using cooling blankets, bladder and stomach cold infusions, washings, etc. The mortality rate was 44%. Potential complications encountered following hypothermia are a rebound increase in ICP on rewarming, ventricular ectopy and fibrillation, coagulopathy, bradycardia, and pneumonia. Herniation from increased ICP during rewarming can occur, necessitating treatment with other agents to lower ICP. Cerebral perfusion pressure, ICP, and brain temperature need to be monitored during induction of hypothermia. Hypothermia can also be combined with other therapies, including hyperosmolar agents and decompressive hemicraniectomy. Table 3 lists the current clinical trials using hypothermia in stroke. Hypothermia is a promising therapy for large hemispheric strokes; however, further randomized clinical trials are needed. 
Surgical Management
Surgical techniques are based on an empiric approach rather than evidence from randomized, controlled studies. Ventriculostomy may reduce ICP by draining cerebrospinal fluid, but may increase focal brain shifts. Resection of the infarcted brain tissue is another option, but separating infarcted brain from potentially viable brain tissue may be impossible. In the past, temporal lobectomy has been tried with limited success. Theoretically, temporal lobectomy may reduce uncal herniation. Decompressive hemicraniectomy with duraplasty is a controversial approach to reduce the catastrophic mass effect of brain edema and tissue displacements (Fig. 2) . The procedure involves generous removal of a frontotemporoparietal bone flap ipsilateral to the side of infarct followed by opening of the dura to allow outward herniation of the brain tissue. 1, 6 The bone flap removed during the procedure can be stored in antibiotic solution at Ϫ70°C and replaced 1 to 3 months later after the brain edema has subsided. Consideration to multiple factors should be given prior to offering hemicraniectomy, including patient age, timing of surgery, dominant versus nondominant hemisphere involvement, and expected long-term disability. Hemicraniectomy is often used as a life-saving procedure with no clear impact on long-term disability and functional outcomes.
Evidence that hemicraniectomy reduces mortality is largely derived from uncontrolled case series and retrospective studies. Early animal studies have revealed that trephination surgery, a form of hemicraniectomy in rats, reduces the 7-day mortality from 35% in the nonsurgical group to almost 0% in the surgical group. 38, 39 Neurologic behavior and infarct volume were favorable in those treated with ultra-early surgery within 4 hours of occlusion, implying the importance of early intervention. Compared with control groups, hemicraniectomy in rats increases perfusion in the cortex and reduces the infarct volume as shown by magnetic resonance imaging (MRI). 40 A review of human case series reports on decompressive hemicraniectomy for large spaceoccupying cerebral infarcts is shown in Table 4 . [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] Hemicraniectomy can also be combined with other techniques that may help synergistically to reduce brain edema. Comparison of moderate hypothermia with hemicraniectomy in massive cerebral infarcts reveals that hemicraniectomy is in fact better, with no difference in intensive medical treatment and duration of stay in the neuro-ICU. In 1 retrospective study, the mortality rate was 47% for the hypothermia group versus 12% for the hemicraniectomy group. 58 Robertson et al 57 reported a case series that combines hemicraniectomy with resection of infarcted tissue. Ten of 12 patients who underwent the procedure survived, 5 ended up with independent or moderate disability, and 5 were left with severe disability. The mortality rate was 16% but the disability rate was high, at 41%, compared with other published case reports.
A number of questions arise when one considers hemicraniectomy for massive cerebral infarcts.
When should hemicraniectomy be offered to patients with large hemispheric infarcts? Hemicraniectomy is usually considered when there are unequivocal clinical and radiologic signs suggestive of impending brain edema and when all other medical measures have failed. Common predictors of brain edema following large hemispheric infarcts include a younger age, nausea, and vomiting within the first 24 hours of admission, National Institutes of Health Stroke Scale score of Ն15 points for right-hemisphere MCA infarction and Ն20 points for lefthemisphere MCA infarction, early hypodensity on the CT scan, midline shift of more than 10 mm at the septum pellucidum level, and MCA infarcts involving more than 50% of the hemisphere. 7 Some authors advocate repeating the CT scan 
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5,59
What is the impact of age on outcomes in patients undergoing hemicraniectomy? Case reports have clearly shown that older patients undergoing hemicraniectomy have poor functional outcomes and increased mortality. 51, 53, 55 This may be because older patients have other comorbid conditions that increase the risk of poor outcomes and mortality. In 1 recent study, age older than 60 years, severe neurologic deficit on admission, longer duration of intensive care treatment, and mechanical ventilation were significantly associated with more severe disability (Barthel Index Ͻ50).
60
Health-related quality of life was considerably impaired in the subscales of mobility, household management, and body care. Some authors strongly recommend hemicraniectomy for younger patients (age Ͻ45 years) on the assumption that young patients are better able to tolerate brain edema and have better functional outcomes given fewer comorbid conditions. 61 Some critics argue that this could be a result of selection bias. At the same time, younger patients have less room for expansion due to absence of age-related atrophy and this could increase the risk of herniation and death. In one analysis of pooled data from case reports and retrospective studies, 14% of patients younger than 50 years died despite surgery compared with 32% older than 50 years of age. Thus, age is a crucial factor in predicting functional outcome after hemicraniectomy in patients with large hemisphere infarcts.
62

Is timing of hemicraniectomy important on outcome?
Animal and clinical studies have provided evidence for benefit from early surgery. In animal MCA occlusion models, early hemicraniectomy at 1 hour versus 24 hours reduces infarct volume significantly. 39 Schwab et al 52 analyzed the influence of early hemicraniectomy (Ͻ24 hours after symptom onset) based on clinical status on admission and initial CT findings versus late surgery (Ͼ24 hours after first reversible signs of herniation) on mortality, and functional outcome. From 31 patients who underwent early hemicraniectomy, mortality was 16% and 84% had a Barthel index more than 60 at the 3-month follow-up. Early hemicraniectomy led to a significant reduction in ICU admission (7.4 days versus 13.3 days, P Ͻ 0.05). On the other hand, late intervention (Ͼ24 hours) has neither been shown to affect outcome nor recovery. Early decompressive surgery should be performed to prevent irreversible damage to adjacent brain tissues. Several other case reports and retrospective studies have revealed the same results. 50, 51, 55 Analysis of pooled published reports suggest that signs of herniation have no impact on the timing of surgery and outcomes. 60 We certainly require randomized, controlled trials to determine the exact timing for hemicraniectomy. Current ongoing clinical trials randomize patients between 12 to 96 hours from symptom onset (Table 5) . Can hemicraniectomy be offered to large, dominanthemisphere infarcts? This is again a very controversial topic. The benefit of hemicraniectomy in dominant hemisphere infarcts appears less convincing due to the fact that the procedure may leave patients with severe aphasia and poor quality of life. Following stroke, there is no cortical reorganization of adjacent areas of normal brain tissue surrounding language areas. 63 However, this is all based on case series and we clearly need a randomized, controlled study to answer this question. A list of current ongoing and completed randomized clinical trials of hemicraniectomy in stroke is shown in Table 5 .
Hemicraniectomy is a life-saving procedure in patients with massive cerebral infarcts. At this time it is not very clear 
CONCLUSION
There is no proven therapy for massive cerebral infarcts. Case series and retrospective studies are difficult to put together to form coherent inference because selection bias prevents valid conclusions. The key pathophysiologic concept is that focal increases in ICP are different from global increases in ICP. Although surgical decompressive craniectomy can save a life and appears more promising than moderate hypothermia, it remains unclear whether this is appropriate given the expected severe disability. Quality of life and social disability measures may be the most important outcomes for future randomized clinical trials. Finally, randomized trials are difficult to perform in both because expertise in the treatment of this disease, either with hypothermia or surgical management is just developing and because the condition is relatively rare.
